R&D Disease X is coming. Are we ready? Every great disaster movie begins with a scientist being ignored.
News WHO declares end of COVID-19 emergency The World Health Organization (WHO) has said that COVID-19 is no longer a public health emergency of international concern (PHEIC), more than three years after it first de
News Merck will appeal EU rejection of COVID drug Lagevrio CHMP says evidence for the drug is “not adequate” to show efficacy over standard care.
News As pandemic abates, NICE issues new COVID drug guidance NICE says it is the first HTA to give guidance on the drugs outside of use during the pandemic.
Digital Connecting patients to treatment on the COVID Care Journey Ada Health and Pfizer have collaborated to launch US nationwide digital COVID-19 Care Journey
News NICE won’t back AZ’s Evusheld for COVID prevention Blood Cancer UK calls for help for the 'forgotten 500,000' who can't be protected with vaccines
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
